We came across a bullish thesis on Merck & Co., Inc. on Darius Dark Investing’s Substack. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.'s share was trading at $101.03 as of December 2nd. MRK’s trailing and forward P/E were 13.47 and 10.83 respectively according to Yahoo Finance.
[caption id="attachment_522188" align="aligncenter" width="750"]Merck & Co. (MRK) stands at a pivotal crossroads as its success with Keytruda, one of the most profitable drugs in history, has created both immense...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.